Roles of m6A modification in oral cancer (Review)

Int J Oncol. 2023 Jan;62(1):5. doi: 10.3892/ijo.2022.5453. Epub 2022 Nov 16.

Abstract

Oral cancer is one of the highly malignant tumors with poor prognosis. The pathogenic mechanisms of oral cancer have remained to be fully elucidated and this brings significant challenges to the treatment. RNA modification is a common intracellular chemical modification that has been related to various pathological processes, such as blood diseases, immune system diseases and cancer. As the most common and abundant RNA modification in eukaryotic mRNA, N6‑methyladenosine (m6A) modification has a crucial role in several cancers, including oral cancer. m6A modification directly affects gene expression levels and regulates various physiological and pathological processes. It has been demonstrated that m6A modification may affect the proliferation, migration and invasion of oral cancer cells by regulating the level of m6A modification. In the present review, the effects of m6A modification on the proliferation and death of oral cancer cells, as well as the occurrence and development of oral cancer, were analyzed in order to provide a new target for treatment. Furthermore, the roles of m6A modification in chemotherapy resistance and potential immunotherapy were analyzed and new treatment ideas were provided.

Keywords: RNA modified; m6A autophagy; metastasis; oral cancer; proliferation.

Publication types

  • Review

MeSH terms

  • Adenosine*
  • Humans
  • Methylation
  • Mouth Neoplasms* / genetics
  • RNA, Messenger / genetics

Substances

  • Adenosine
  • RNA, Messenger

Grants and funding

This work was supported by the Fundamental Research Funds for the Jilin Province Department of Finance (grant no. jcsz2021893-13), the Changchun Scientific and Technological Development Program (grant no. 21ZY26), the Jilin Province Scientific and Technological Development Program (grant nos. 20200801077GH, 20210204013YY, 20200504005YY and 20220505033ZP) and Scientific Research Project of Traditional Chinese Medicine Bureau of Guangdong Province (grant no. 20201236).